E-Z-EM's abdominal contrast agent business, along with the healthcare decontamination and the GI device businesses, will be integrated into Bracco Diagnostics.

Bracco said that E-Z-EM contrast delivery, contrast data management and point of care testing system businesses will move to ACIST Medical Systems, part of the Bracco Group.

Diana Bracco, chairman and CEO of the Bracco Group, said that

«« Inchingolo International Master's Thesis Award Deadline Approaching


New Interventional Technique May Save Eyesight »»


Latest Articles

E-Z-EM's abdominal contrast agent business, along with the healthcare decontamination and the GI device businesses, will be integrated into Bracco Diagno...